Ventricular Assist Device Market Opportunities, Business Forecast To 2029

The global ventricular assist device market size was valued at USD 1,950.0 million in 2021 and is poised to grow at a CAGR of 8.3% during the forecast period 2023 to 2029. The Ventricular Assist Device (VAD) market refers to the market for medical devices that are used to assist or replace the function of a patient's failing heart. A Ventricular Assist Device is an implantable mechanical pump that helps the weakened heart to pump blood to the rest of the body. VADs can be used as a bridge to transplantation, as a permanent treatment option, or as a bridge to recovery for patients with reversible heart failure. The devices are implanted during surgery and connected to the patient's heart and blood vessels to assist or replace the function of the left or right ventricle or both. The VAD market includes different types of devices such as Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs), and Total Artificial Hearts (TAHs).

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ventricular-assist-device-market/

Ventricular Assist Device Market Growth Factors:
The Ventricular Assist Device (VAD) market is expected to grow due to the following growth drivers:
The prevalence of heart failure is increasing globally due to lifestyle changes, the aging population, and the rise in chronic diseases such as diabetes and hypertension. As a result, the demand for VADs as a treatment option for heart failure is increasing.

Technological advancements in VADs have led to the development of more efficient, durable, and smaller devices. These advancements have made VADs a more viable treatment option for a larger patient population, including pediatric and elderly patients.

The adoption of VADs is increasing in developing countries due to rising healthcare expenditure, increasing awareness, and improving healthcare infrastructure. Additionally, the high cost of heart transplants and the limited availability of donor hearts in these regions are driving the demand for VADs as an alternative treatment option.
The shortage of donor hearts for transplantation is a major factor driving the growth of the VAD market. VADs can provide an alternative treatment option for patients with heart failure who are not eligible for transplantation or who are waiting for a donor's heart.

The global ventricular assist device market segmentation:
1) By Product: Left Ventricular Assist Device, Right Ventricular Assist Device, Bi-Ventricular Assist Device, Total Artificial Heart.
2) By Type: Pulsatile Flow, Continuous Flow.
3) By Design: Implantable Ventricular Assist Device, Transcutaneous Ventricular Assist Device.
4) by Application: Bridge to Transplant, Destination Therapy, Others.

Ventricular Assist Device Market Regional Analysis:
The Ventricular Assist Device (VAD) market is a global market with significant growth potential in various regions. Here is a brief regional analysis of the market:

North America: North America is the largest market for VADs, driven by the increasing prevalence of heart failure, advancements in technology, and favorable reimbursement policies. The United States is the major market in the region, followed by Canada.

Europe: Europe is the second-largest market for VADs, driven by the aging population and increasing prevalence of heart failure. The region also has a well-established healthcare infrastructure and favorable reimbursement policies. The United Kingdom, Germany, and France are the major markets in the region.

Asia-Pacific: The Asia-Pacific region is witnessing rapid growth in the VAD market due to the increasing adoption of VADs in developing countries, rising healthcare expenditure, and improving healthcare infrastructure. China, Japan, and India are the major markets in the region.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=55990

Key players in the ventricular assist device market Abbott (US), Reliant Heart Inc. (US), Abiomed Inc. (US), Cardiac Assist Inc. (US), Cirtec (US), CorWave SA (France), Medtronic plc (Ireland), Fineheart (France), Berlin Heart GmbH (Germany)

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.